Portrait of Moody, Ashley

Moody, Ashley

U.S. Senator FL Republican Party

Congressional stock trade history disclosed under the STOCK Act, parsed and scored by FilingIQ.

Disclosed trades
52
Buys / sells
31% / 69%
Last trade
Apr 4, 2025
Last filing
May 13, 2025

Latest disclosed trades

Latest 10 of 52
Ticker Type Traded
— HWM Buy Apr 4, 2025
— ET Buy Apr 4, 2025
— ARCC Buy Apr 4, 2025
— JPM Buy Apr 4, 2025
— SMCI Buy Mar 25, 2025
— NVDA CALL Sell Mar 25, 2025
— SMCI CALL Sell Mar 25, 2025
— SMCI PUT Sell Mar 25, 2025
— SMCI Sell Mar 24, 2025
— NVDA Buy Mar 21, 2025

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window, and to see the FilingIQ Score on every trade.

Moody, Ashley stock trade activity

FilingIQ has indexed 52 congressional stock trade disclosures for Moody, Ashley. The most recent disclosed transaction is dated Apr 4, 2025.

Across the full history, 16 purchases and 36 sales have been disclosed under the STOCK Act.

Top tickers traded by Moody, Ashley

Frequently asked

How many stock trades has Moody, Ashley disclosed?
FilingIQ tracks 52 Periodic Transaction Report disclosures for Moody, Ashley, with the most recent dated Apr 4, 2025. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Moody, Ashley a net buyer or net seller?
Across the disclosed trade history, 16 (31%) were purchases and 36 (69%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Moody, Ashley come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.